NDC 0187-0141

Vasotec

Enalapril Maleate

Vasotec is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Valeant Pharmaceuticals North America Llc. The primary component is Enalapril Maleate.

Product ID0187-0141_0af21216-515e-4b5d-86db-19947d725e77
NDC0187-0141
Product TypeHuman Prescription Drug
Proprietary NameVasotec
Generic NameEnalapril Maleate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1985-12-24
Marketing CategoryNDA / NDA
Application NumberNDA018998
Labeler NameValeant Pharmaceuticals North America LLC
Substance NameENALAPRIL MALEATE
Active Ingredient Strength5 mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0187-0141-30

30 TABLET in 1 BOTTLE (0187-0141-30)
Marketing Start Date1985-12-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0187-0141-30 [00187014130]

Vasotec TABLET
Marketing CategoryNDA
Application NumberNDA018998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1985-12-24

NDC 0187-0141-90 [00187014190]

Vasotec TABLET
Marketing CategoryNDA
Application NumberNDA018998
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1985-12-24

NDC 0187-0141-10 [00187014110]

Vasotec TABLET
Marketing CategoryNDA
Application NumberNDA018998
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1985-12-24
Marketing End Date2014-03-31

Drug Details

Active Ingredients

IngredientStrength
ENALAPRIL MALEATE5 mg/1

OpenFDA Data

SPL SET ID:39631f1f-5d19-43c1-b504-bf56d991ed97
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 858817
  • 858819
  • 858815
  • 858804
  • 858810
  • 858806
  • 858812
  • 858813

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • Decreased Blood Pressure [PE]
    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • Decreased Blood Pressure [PE]

    NDC Crossover Matching brand name "Vasotec" or generic name "Enalapril Maleate"

    NDCBrand NameGeneric Name
    0187-0140VasotecEnalapril Maleate
    0187-0141VasotecEnalapril Maleate
    0187-0142VasotecEnalapril Maleate
    0187-0143VasotecEnalapril Maleate
    70518-0624VasotecVasotec
    70518-1372VasotecVasotec
    70518-1626VasotecVasotec
    70518-1958VasotecVasotec
    0093-0026Enalapril MaleateEnalapril Maleate
    0093-0027Enalapril MaleateEnalapril Maleate
    0093-0028Enalapril MaleateEnalapril Maleate
    0093-0029Enalapril MaleateEnalapril Maleate
    0378-1052Enalapril MaleateEnalapril Maleate
    0615-4589ENALAPRIL MALEATEENALAPRIL MALEATE
    0615-4590ENALAPRIL MALEATEENALAPRIL MALEATE
    0615-4591ENALAPRIL MALEATEENALAPRIL MALEATE
    0615-4593ENALAPRIL MALEATEENALAPRIL MALEATE
    0615-7907Enalapril MaleateEnalapril Maleate
    0615-7908Enalapril MaleateEnalapril Maleate
    0615-7909Enalapril MaleateEnalapril Maleate
    0904-5502ENALAPRIL MALEATEENALAPRIL MALEATE
    0904-5609ENALAPRIL MALEATEENALAPRIL MALEATE
    0904-5610ENALAPRIL MALEATEENALAPRIL MALEATE
    0904-5611ENALAPRIL MALEATEENALAPRIL MALEATE
    10544-170ENALAPRIL MALEATEENALAPRIL MALEATE
    10544-195Enalapril MaleateEnalapril Maleate
    10544-293Enalapril MaleateEnalapril Maleate
    10544-632Enalapril MaleateEnalapril Maleate
    10544-633Enalapril MaleateEnalapril Maleate
    16714-442Enalapril Maleateenalapril maleate
    16714-443Enalapril Maleateenalapril maleate
    16714-444Enalapril Maleateenalapril maleate
    16714-445Enalapril Maleateenalapril maleate
    21695-487ENALAPRIL MALEATEENALAPRIL MALEATE
    21695-488ENALAPRIL MALEATEENALAPRIL MALEATE
    21695-489ENALAPRIL MALEATEENALAPRIL MALEATE
    23155-704Enalapril maleateEnalapril maleate

    Trademark Results [Vasotec]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VASOTEC
    VASOTEC
    73465852 1348858 Live/Registered
    Merck & Co., Inc.
    1984-02-15
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.